• Return to Headlines

Recent 52-Week High Exceeded in Shares of Haemonetics Corp (HAE)

By Amy Schwartz

Haemonetics Corp (NYSE:HAE) traded today at a new 52-week high of $119.66. Approximately 92,000 shares have changed hands today, as compared to an average 30-day volume of 543,000 shares.

Haemonetics Corp (NYSE:HAE) is currently priced 27.9% above its average consensus analyst price target of $86.33. Haemonetics Corp shares have support at the 200-day moving average (MA) of $98.89 and additional support at the 50-day MA of $96.78.

Haemonetics Corp share prices have moved between a 52-week high of $119.66 and a 52-week low of $80.23 and are now trading 49% above that low price at $119.66 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.6% while the 200-day MA has remained constant.

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company operates through five segments: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan.

SmarTrend recommended that subscribers consider buying shares of Haemonetics Corp on May 1st, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $89.64. Since that recommendation, shares of Haemonetics Corp have risen 30.6%. We continue to monitor HAE for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows haemonetics corp

Ticker(s): HAE